(R) -SL18
(R) -SL18 is a degrader of ANXA3 and can degrade ANXA3 protein through the ubiquitination pathway. (R) -SL18 inhibits the proliferation, migration, invasion, and colony formation of breast cancer cells and induces apoptosis. (R) -SL18 can be used in the research of triple-negative breast cancer[1].
Product Specifications
CAS Number
3023189-40-1
UNSPSC
12352101
Target
Annexin A; Apoptosis
Related Pathways
Apoptosis; Cytoskeleton
Field of Research
Cancer
Smiles
CN1C2=CC=CC=C2C(C3=CC=CC=C3)=N[C@@H](NC(SCC(NC(NC4=CC(Cl)=CC=C4[N+]([O-])=O)=O)=O)=S)C1=O
Molecular Formula
C26H21ClN6O5S2
Molecular Weight
597.07
References & Citations
[1]Liu K, et al. Discovery of a Novel 1,4-Benzodiazepine Derivative as a Highly Selective ANXA3 Degrader for the Treatment of Triple-Negative Breast Cancer. J Med Chem. 2025 Feb 27.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
AnxA3
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC470029-100 1x 100 µL
Fibronectin (TV-1), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC680181-100 1x 100 µL
CD59 (heavy chain of Protectin) (BRA-10G), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC741227-100 1x 100 µL
Thyroglobulin (TGB04 + TGB05), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC680183-500 1x 500 µL
Cytochrome C (Mitochondrial Marker) (7H8.2C12), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details